A small-molecule compound D6 overcomes EGFR-T790M-mediated resistance in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is a deadly and highly prevalent malignancy. Targeting activated-EGFR mutations in NSCLC via EGFR tyrosine kinase inhibitor (EGFR-TKI) initially achieves a profound therapeutic response, but resistance frequently evolves, reducing treatment options. Here, we presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xiaolong, Cheng, Lizhi, Li, Guo, Yan, Yong-Ming, Su, Fengting, Huang, Dan-Ling, Zhang, Shuping, Liu, Zuojun, Qian, Minxian, Li, Ji, Cheng, Yong-Xian, Liu, Baohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668973/
https://www.ncbi.nlm.nih.gov/pubmed/34903832
http://dx.doi.org/10.1038/s42003-021-02906-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668973/
https://www.ncbi.nlm.nih.gov/pubmed/34903832
http://dx.doi.org/10.1038/s42003-021-02906-4

Ejemplares similares